
Ilmari Parkkinen
@iparkkinen
Neuroscience, pharmacology, drug discovery & development. PhD in neuropharmacology.
ID: 594879796
30-05-2012 20:19:36
5,5K Tweet
305 Followers
586 Following










GDNF, a neurotrophic factor, reduces protein aggregation pathology in midbrain neurons despite the defective protein degradation. Final article from my PhD is published, open-access: sciencedirect.com/science/articl… Life Sciences University of Helsinki University of Helsinki MDS The Science of Parkinson's (1/7)



Top companies and drugs by sales in 2024 tinyurl.com/yc22rzsh Merck & Co’s cancer immunotherapy Keytruda solidified its top place, and GLP-1 receptor agonists for diabetes and obesity are shaking up the rankings. Read more in this new analysis by Paul Verdin Evaluate Pharma







